22-26.9.2014 - Neural Development and Neurodevelopmental Disorders

Condividi su
Data dell'evento: dal 22/09/2014 al 26/09/2014
dottorato_taglio

PhD Program in Neuroscience
Doctoral School in Life and Health Sciences
SEPTEMBER 22-26, 2014
Neural Development
and Neurodevelopmental Disorders

Department of Life Sciences and Systems Biology & Department of Neuroscience “Rita Levi Montalcini”
University of Turin
The course will be held SEPTEMBER 22-26, 2014 and will take place at the Department of Life Sciences and Systems Biology & Department of Neuroscience “Rita Levi Montalcini”, University of Turin – Italy.

TOPICS: this course will introduce students to cutting-edge research on topics ranging from brain patterning, neurogenesis, cell fate specification, synapse formation and plasticity, to new insights on genetic, clinical, therapeutic and cognitive aspects of neurodevelopmental disorders.
The total number of participants will be limited to 50 students, and registrations will be dealt with on a first come, first served basis.
In the context of a new program for integrated higher education and training in Neuroscience, FENS in partnership with IBRO provides stipends of 750 EUR for international students interested in attending this course.
See the PDF file for the Program and Registration instructions.

Doctoral School in Life and Health Sciences

dottorato

Agenda

16 febbraio 2019

Torino - 10th International Meeting STEROIDS and NERVOUS SYSTEM

Since 2001, this meeting represented an important event for basic and clinical researchers working on this emerging scientific topic. We will address state-of-the-art approaches in the field of steroids and nervous system, including behavior, epigenetics, genomic and non-genomic actions, the vitamin D, neurodegenerative and psychiatric disorders, and the interference among endocrine disruptors and steroid signaling.

Ricerca

Identificato un nuovo bersaglio per contrastare la SMA

L’inibizione della proteina JNK rallenta la progressione della malattia che colpisce i motoneuroni ed è la prima causa genetica di morte nell’infanzia. Lo dimostra uno studio pubblicato su Frontiers in Molecular Neuroscience dal nostro gruppo di ricerca guidato da Alessandro Vercelli, in collaborazione con l’Istituto Mario Negri di Milano. Chiarire i meccanismi molecolari alla base della SMA può aprire la strada allo sviluppo di nuove terapie.

24 ottobre 2018